Citurgia Biochemicals Limited reported a net loss of ₹74.25 lakh for the financial year ended March 31, 2026, widening from a net loss of ₹42.31 lakh in the previous year. The company recorded zero revenue from operations for the period, while total expenses increased to ₹74.25 lakh from ₹42.31 lakh in FY25. The Board of Directors approved the audited standalone financial results for the quarter and year ended March 31, 2026, at a meeting held on May 30, 2026.

The statutory auditors, M/s. G.P. Keshri & Associates, issued an unmodified audit report on the financial results. The company reported a net loss of ₹25.82 lakh for the quarter ended March 31, 2026, compared to a net loss of ₹11.93 lakh in the corresponding quarter of the previous year. Total expenses for the quarter stood at ₹25.82 lakh, up from ₹11.93 lakh in the same period last year.

Financial Performance

The company's financial results for the year ended March 31, 2026, reflect a continued period of operational inactivity with respect to revenue generation. The primary components of the expenses included employee benefit expenses, depreciation, and other costs.

Assets and Liabilities

As of March 31, 2026, the company's total assets stood at ₹1,047.04 lakh, a decrease from ₹1,076.40 lakh in the previous year. The equity position showed a negative balance of ₹773.41 lakh, compared to a negative balance of ₹699.16 lakh in the prior year.

The cash flow statement indicated a net increase in cash and cash equivalents of ₹0.81 lakh for the financial year, bringing the closing balance to ₹12.69 lakh. The trading window for the company's equity shares, which was closed from April 1, 2026, will open 48 hours after the financial results are declared to the stock exchanges.

Citurgia Biochemicals Limited filed its Annual Secretarial Compliance Report for the financial year ended March 31, 2026, confirming adherence to applicable statutory provisions despite operational constraints caused by a prior trading suspension. The report, issued by M/s. Sumit Bajaj & Associates, highlights that the company has complied with the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, except for specific delays in filings during the suspension period.

During the year under review, the trading in the equity shares of the listed entity was suspended. The company had filed an application for revocation of suspension with the Stock Exchange, and the suspension was subsequently revoked with effect from February 09, 2026. This suspension and related operational constraints were cited as reasons for delays in submitting the Annual Secretarial Compliance Report for the financial year ended March 31, 2025, as well as delays in submitting the Annual Report and Financial Results for that period.

The practicing company secretaries identified three specific deviations from compliance timelines for the previous financial year. These included the non-submission of the Annual Secretarial Compliance Report within 60 days, a delay in submitting the Annual Report, and a delay in submitting Financial Results. In all instances, the action taken by the authorities was recorded as an advisory, with the potential for fines as may be levied by the Stock Exchange.

Management attributed these delays to the suspension of trading and the resulting operational challenges. The company stated that it is taking necessary steps to ensure timely compliance and submission of all applicable filings in the future. The report advised the company to strengthen its internal compliance and monitoring mechanisms to avoid recurrence of such delays.

Regarding the compliance status for FY26, the report confirmed that the listed entity has complied with Secretarial Standards issued by the Institute of Company Secretaries of India and has adopted and updated all applicable policies under SEBI Regulations. The company maintains a functional website with timely dissemination of documents. No directors were disqualified under Section 164 of the Companies Act, 2013, and the company does not have any subsidiaries or related party transactions during the year.

The report also noted that the company appointed a Chief Financial Officer on May 28, 2026, in compliance with Section 203 of the Companies Act, 2013 and the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. There were no reportable events concerning the resignation of statutory auditors during the financial year.